Inventor · disambiguated record
Guizhong Liu
Also filed as: LIU GUIZHONG
6 granted patents·15 pending applications·21 citations·filing 2018–2024
77Inventor score
Top patents by PatentIndex Score
21 records- 0192US11242395B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2018·Granted Feb 8, 2022·13 cites·29 claims
- 0288US11359016B2Anti-CTLA4 antibodies and methods of making and using the sameADAGENE INC·Filed 2019·Granted Jun 14, 2022·5 cites·40 claims
- 0386US11859003B2Method for treating cancer using anti-CD137 antibodyADAGENE INC·Filed 2018·Granted Jan 2, 2024·3 cites·18 claims
- 0475US2024141046A1Anti-ctla4 antibodies and methods of making and using the sameADAGENE INC·Filed 2023·Application pending·0 cites
- 0571US12378319B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2021·Granted Aug 5, 2025·0 cites·13 claims
- 0665US2024279350A1CD40-Binding ProteinsSANOFI SA·Filed 2024·Application pending·0 cites
- 0764US11692036B2Anti-CTLA4 antibodies and methods of making and using the sameADAGENE INC·Filed 2019·Granted Jul 4, 2023·0 cites·28 claims
- 0862US2024262923A1Anti-pd-1×4-1bb binding proteinsGENZYME CORP·Filed 2023·Application pending·0 cites
- 0961US2025257133A1Anti-CD28 Antibodies and Methods of Use ThereofADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 1061US2025188179A1Anti-cd137 antibodies and methods of making and using the sameADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 1159US2025326847A1Activatable anti-ctla4 antibodies for treating cancerADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 1257US2024417463A1Anti-cd47 antibodies and methods of use thereofADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 1356US2024209092A1Combination therapies for treating cancerADAGENE INC·Filed 2022·Application pending·0 cites
- 1456US2025326860A1Anti-cd3 antibodies and methods of use thereofADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 1555US12054548B2Anti-PD-L1 antibodies and use thereofADAGENE INC·Filed 2019·Granted Aug 6, 2024·0 cites·11 claims
- 1654US2024209091A1Methods for treating cancer using anti-ctla4 antibodiesADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 1752US2023242663A1Combination therapy comprising anti-cd137 antibodiesADAGENE PTE LTD·Filed 2021·Application pending·0 cites
- 1851US2023133118A1Compositions and methods for treating cancerADAGENE AG·Filed 2021·Application pending·0 cites
- 1947US2022089757A1Anti-cd137l antibodies and methods of using sameADAGENE PTE LTD·Filed 2020·Application pending·0 cites
- 2045US2020377608A1Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibodyLUO PETER PEIZHI·Filed 2018·Application pending·0 cites
- 2145US2023124669A1Heterodimeric proteins with fc mutationsADAGENE AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guizhong Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →